Vanessa Petry

1.2k total citations
24 papers, 366 citations indexed

About

Vanessa Petry is a scholar working on Oncology, Dermatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vanessa Petry has authored 24 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Dermatology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vanessa Petry's work include Dermatology and Skin Diseases (5 papers), Cancer Treatment and Pharmacology (5 papers) and HER2/EGFR in Cancer Research (5 papers). Vanessa Petry is often cited by papers focused on Dermatology and Skin Diseases (5 papers), Cancer Treatment and Pharmacology (5 papers) and HER2/EGFR in Cancer Research (5 papers). Vanessa Petry collaborates with scholars based in Brazil, United States and Japan. Vanessa Petry's co-authors include Magda Blessmann Weber, Anja Rinke, Paulo M. Hoff, Hanna Daniel, Thomas M. Gress, Michael E. Scharf, Pedro Alves d’Azevedo, Renan Rangel Bonamigo, Max S. Mano and Roberto Hegg and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Vanessa Petry

23 papers receiving 356 citations

Peers

Vanessa Petry
Anna Pawłowska United States
Dace Shugg Australia
Gino Crivellari Italy
Julie K. Jang United States
Víctor Martínez Spain
Anne Feyler France
Jackie Hodgetts United Kingdom
F. Amatore France
Adam Yen United States
Matthew E. Witek United States
Anna Pawłowska United States
Vanessa Petry
Citations per year, relative to Vanessa Petry Vanessa Petry (= 1×) peers Anna Pawłowska

Countries citing papers authored by Vanessa Petry

Since Specialization
Citations

This map shows the geographic impact of Vanessa Petry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Petry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Petry more than expected).

Fields of papers citing papers by Vanessa Petry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Petry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Petry. The network helps show where Vanessa Petry may publish in the future.

Co-authorship network of co-authors of Vanessa Petry

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Petry. A scholar is included among the top collaborators of Vanessa Petry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Petry. Vanessa Petry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rugo, Hope S., Eriko Tokunaga, Hiroji Iwata, et al.. (2025). Pooled analysis of trastuzumab deruxtecan retreatment after recovery from grade 1 interstitial lung disease/pneumonitis. Annals of Oncology. 36(11). 1389–1399. 1 indexed citations
2.
Rugo, H. S., Eriko Tokunaga, Hiroji Iwata, et al.. (2024). 267MO Pooled analysis of trastuzumab deruxtecan (T-DXd) retreatment (RTx) after recovery from grade (Gr) 1 interstitial lung disease/pneumonitis (ILD). ESMO Open. 9. 103326–103326. 3 indexed citations
3.
Petry, Vanessa, et al.. (2024). Frequency of Radiation Therapy-Induced Malignancies in Patients With Li-Fraumeni Syndrome and Early-Stage Breast Cancer and the Influence of Radiation Therapy Technique. International Journal of Radiation Oncology*Biology*Physics. 119(4). 1086–1091. 4 indexed citations
4.
Petry, Vanessa, et al.. (2023). A matched case-control study of the prognosis of early breast cancer in patients with Li-Fraumeni syndrome (BREAST TP53). The Breast. 68. 157–162. 2 indexed citations
5.
Petry, Vanessa, et al.. (2023). Abstract P1-03-05: Overview of the management and factors associated with outcomes of metastatic breast cancer among elderly patients. Cancer Research. 83(5_Supplement). P1–3. 1 indexed citations
6.
Bonadio, Renata Colombo, et al.. (2022). 179P Does undertreatment of elderly patients with early breast cancer impact outcome?. Annals of Oncology. 33. S619–S619.
7.
Petry, Vanessa, et al.. (2019). Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li–Fraumeni syndrome). Familial Cancer. 19(1). 47–53. 24 indexed citations
8.
Balderrama-Brondani, Vania, Vanessa Petry, Maria Cláudia Nogueira Zerbini, et al.. (2019). Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation. The Journal of Steroid Biochemistry and Molecular Biology. 190. 250–255. 21 indexed citations
9.
Arai, Roberto Jun, Vanessa Petry, Paulo M. Hoff, & Max S. Mano. (2018). Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapy. Biomarker Research. 6(1). 20–20. 8 indexed citations
10.
Scharf, Michael E., Vanessa Petry, Hanna Daniel, Anja Rinke, & Thomas M. Gress. (2017). Bone Metastases in Patients with Neuroendocrine Neoplasm: Frequency and Clinical, Therapeutic, and Prognostic Relevance. Neuroendocrinology. 106(1). 30–37. 45 indexed citations
11.
Petry, Vanessa, Alessandro Leal, Roberto Jun Arai, et al.. (2015). Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer. Brazilian Journal of Medical and Biological Research. 48(5). 479–485. 8 indexed citations
12.
Fonseca, Leonardo Gomes da, Débora De Melo Gagliato, Milena Perez Mak, et al.. (2014). Cardiac Safety of (Neo)Adjuvant Trastuzumab in the Community Setting: A Single-Center Experience. Breast Care. 9(4). 255–260. 6 indexed citations
13.
Petry, Vanessa, et al.. (2013). Prevalence of community‐acquired methicillin‐resistant Staphylococcus aureus and antibiotic resistance in patients with atopic dermatitis in Porto Alegre, Brazil. International Journal of Dermatology. 53(6). 731–735. 19 indexed citations
14.
Petry, Vanessa, et al.. (2012). Bacterial skin colonization and infections in patients with atopic dermatitis. Anais Brasileiros de Dermatologia. 87(5). 729–734. 31 indexed citations
15.
Testa, Laura, Rômulo Leopoldo de Paula Costa, M. Ferrari, et al.. (2012). Feasibility of two schedules of weekly paclitaxel as (neo)adjuvant treatment for patients (PTS) with HER2-negative breast cancer (BC) in the Brazilian community setting.. Journal of Clinical Oncology. 30(27_suppl). 122–122. 2 indexed citations
16.
Petry, Vanessa, et al.. (2011). Identificação de espécies de malassésia na pitiríase versicolor em um serviço de dermatologia do sul do Brasil. Anais Brasileiros de Dermatologia. 86(4). 803–806. 15 indexed citations
17.
Petry, Vanessa & Anthony A. Gaspari. (2009). Toll-like receptors and dermatology. International Journal of Dermatology. 48(6). 558–570. 8 indexed citations
18.
Petry, Vanessa, et al.. (2008). Relação entre de prurido e qualidade de vida de pacientes em hemodiálise. Anais Brasileiros de Dermatologia. 83(2). 137–140. 12 indexed citations
19.
Weber, Magda Blessmann, et al.. (2005). Avaliação da relação do prurido e níveis sangüíneos de IgE com a gravidade do quadro clínico em pacientes com dermatite atópica * Evaluating the relation between pruritus, serum IgE levels and severity of clinical manifestations in atopic dermatitis patients *. 1 indexed citations
20.
Weber, Magda Blessmann, et al.. (2005). Avaliação da relação do prurido e níveis sangüíneos de IgE com a gravidade do quadro clínico em pacientes com dermatite atópica. Anais Brasileiros de Dermatologia. 80(3). 245–248. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Pawłowska Breakdown of academic impact, for papers by Dace Shugg Breakdown of academic impact, for papers by Gino Crivellari Breakdown of academic impact, for papers by Julie K. Jang Breakdown of academic impact, for papers by Víctor Martínez Breakdown of academic impact, for papers by Anne Feyler Breakdown of academic impact, for papers by Jackie Hodgetts Breakdown of academic impact, for papers by F. Amatore Breakdown of academic impact, for papers by Adam Yen Breakdown of academic impact, for papers by Matthew E. Witek
Rankless by CCL
2026